Barclays Maintains Overweight on BIOVF Swedish Orphan Biovitrum Feb 2026
Barclays maintained Overweight on BIOVF with a higher SEK 470 price target in Feb 2026; BIOVF analyst rating coverage explained
Barclays maintained Overweight on BIOVF with a higher SEK 470 price target in Feb 2026; BIOVF analyst rating coverage explained
TRON USD price analysis: TRXUSD at $0.2836 with 0.49706% daily gain. Technical levels, forecast, and market sentiment for February 2026.
Goldman Sachs maintains Buy and raises price target for Barry Callebaut; BRRLY analyst rating stays Buy
Pre-market earnings spotlight: GALP.LS stock at €18.42 ahead of 2 Mar 2026 results; model sees €15.22 yearly projection
Chester NY detention center plan shifts as DHS advances a warehouse purchase and ICE signals a pause, while New Windsor protests rise. Key risks for contractors and local finance.
Pre-market note: VPOL.SW stock at CHF0.3775, RSI 20 signals oversold bounce; targets CHF0.59 and CHF0.70
After-hours update on 9432.T stock at JPY 150.80 with volume 231,468,300 on JPX; analysis and Meyka AI forecast
Intraday update on 2160.HK stock at HK$3.89 with heavy volume and overbought technicals
Pre-market high-volume mover: 1H50.F stock at €0.05 with a volume spike and Meyka AI forecast of €0.08
Shein IPO latest: Founder Sky Xu pledges ¥10B for Guangdong supply chain as offshore listing stalls. What this means for timing, valuation, and India-focused investors.